Monitor for the Board's decision on the reverse stock split ratio and timing, as well as any subsequent warrant exercises at the reduced $0.85 price, which could increase share count by up to 4.7 million shares.
Price Chart
Executive Summary
VivoSim Labs held its 2026 Annual Meeting on September 30, 2026. Stockholders approved a 3,165,000-share increase to the 2022 Equity Incentive Plan, a reverse stock split (1:5 to 1:20 range), and the issuance of 4,705,883 shares upon exercise of warrants with a price reduction from $9.60 to $0.85. The filing is routine post-meeting disclosure with no financial results or material operational changes.
Key Facts
- Stockholders approved an amendment to increase shares reserved under the 2022 Equity Incentive Plan by 3,165,000 shares (72.52% approval).
- Stockholders approved a reverse stock split at a ratio between 1:5 and 1:20, at the Board's discretion, by September 30, 2027 (74.12% approval).
- Stockholders approved the issuance of 4,705,883 shares upon exercise of warrants and a reduction of the exercise price of certain warrants from $9.60 to $0.85 per share (77.87% approval).
- Keith Murphy and Adam Stern were elected as Class III directors until the 2029 Annual Meeting.
- Rosenberg Rich Baker Berman P.A. was ratified as independent auditor for fiscal year ending March 31, 2027 (92.51% approval).
- Advisory vote on named executive officer compensation passed with 76.33% approval.
- Only 37.26% of outstanding shares (6,180,635 of 16,586,495) were represented at the meeting.
Financial Impact
No financial results reported. The equity plan increase and warrant exercise approvals enable future equity issuance but no immediate cash impact.
Risk Factors
- Potential dilution from the 3,165,000 new shares authorized under the equity plan and the 4,705,883 shares from warrant exercises.
- Low shareholder turnout (37.26%) may indicate limited retail engagement.
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-415542 |
| Document: vivs-20260930.htm | 0001193125-26-415542 |
| Document: 0001193125-26-415542-index-headers.html | 0001193125-26-415542 |
| Document: 0001193125-26-415542-index.html | 0001193125-26-415542 |
| Document: 0001193125-26-415542.txt | 0001193125-26-415542 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 10d ago | 8-K | $0.1575 $0.1520 | ▲ +3.49% | ▲ +3.35% | $0.1500 (+4.76%) |
Oct 6, 2026 20d ago | 8-K | $0.1915 $0.1609 | ▼ −15.98% | ▼ −15.00% | $0.1500 (−21.67%) |
Sep 16, 2026 5w ago | Press Release | $0.2621 $0.2291 | ▼ −12.59% | ▼ −15.15% | $0.1500 (−42.77%) |
Aug 11, 2026 10w ago | EFFECT | $0.3526 $0.2786 | ▲ +20.99% | ▲ +20.58% | $0.1500 (+57.46%) |
Aug 6, 2026 11w ago | 8-K | $0.3299 $0.3281 | ▼ −0.55% | ▼ −1.76% | $0.1500 (−54.53%) |
Jul 17, 2026 14w ago | 8-K | $0.5790 $0.4500 | ▲ +22.28% | ▲ +21.59% | $0.1500 (+74.09%) |
Apr 3, 2026 29w ago | 8-K | $1.71 $1.44 | ▼ −15.79% | ▼ −19.92% | $0.1500 (−91.23%) |
Apr 1, 2026 29w ago | Press Release | $1.62 $1.53 | ▲ +5.56% | ▲ +9.32% | $0.1500 (+90.74%) |
Apr 1, 2026 29w ago | EFFECT | $1.62 $1.53 | ▼ −5.56% | ▼ −9.32% | $0.1500 (−90.74%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers